Piperidine and azetidine derivatives as glyt1 inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/12 (2006.01) A61K 31/4178 (2006.01) A61K 31/4439 (2006.01) A61K 31/4545 (2006.01) A61P 25/18 (2006.01) C07D 401/12 (2006.01)

Patent

CA 2592345

The present invention provides compounds of formula (I), wherein both p's are one or two, R1 is generally heteroaryl or cycloalkyl, R2 is C3-6cycloalkyl or phenyl and R3 is heteroaryl, and pharmaceutically acceptable salts thereof, as GlyT1 inhibitors for treating schizophrenia, pharmaceutical compositions comprising the same and methods for their preparation.

La présente invention concerne des composés de formule (I), ou les deux p sont égaux à un ou à deux, R1 représente généralement un hétéroaryle ou un cycloalkyle, R2 représente un cycloalkyle en C3-C6 ou un phényle et R3 représente un groupement hétéroaryle, ainsi que des sels de qualité pharmaceutique de ces composés, en tant qu'inhibiteurs de GlyT1. Lesdits composés et leurs sels entrent dans le traitement de la schizophrénie. La présente invention concerne également des préparations pharmaceutiques comprenant lesdits composés et leurs sels, ainsi que des méthodes de synthèse desdits composés et de leurs sels.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperidine and azetidine derivatives as glyt1 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine and azetidine derivatives as glyt1 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine and azetidine derivatives as glyt1 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1582159

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.